KMPH News

Etsy exploded 88% out of the gate, giving it the best first-day return for a tech IPO in over a year. Cancer immunotherapy biotech Aduro Biotech flew up 147%, the year's third IPO to more than double on day one. This past week was the second largest of 2015 by proceeds raised as four companies went public at billion-dollar valuations, up from a week with two in January. 43 IPOs...read more

KemPharm, a late-stage biotech developing abuse-deterrent versions of widely-prescribed pain medications, raised $56 million by offering 5.1 million shares at $11, below the range of $12 to $14. The company originally planned to offer 4.0 million shares. KemPharm plans to list on the NASDAQ under the symbol KMPH. KemPharm initially filed confidentially on 12/19/2014. Cowen &...read more

As many as seven IPOs could price this week, and four have a proposed market cap over $1 billion. So far, only eight companies that large have gone public this year, or 22% of all deals. The 3 largest - Party City, Etsy and Virtu - are based in New York. ...read more

KemPharm, which is developing abuse-deterrent versions of widely-prescribed pain medications, announced terms for its IPO on Friday. The Coralville, IA-based company plans to raise $52 million by offering 4 million shares at a price range of $12 to $14. At the midpoint of the proposed range, KemPharm would command a fully diluted market value of $207 million. KemPharm,...read more